Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
G Klement, S Baruchel, J Rak, S Man… - The Journal of …, 2000 - Am Soc Clin Investig
Various conventional chemotherapeutic drugs can block angiogenesis or even kill activated,
dividing endothelial cells. Such effects may contribute to the antitumor efficacy of …
dividing endothelial cells. Such effects may contribute to the antitumor efficacy of …
Photo elicitation interview (PEI): Using photos to elicit children's perspectives
…, P McKeever, S Baruchel - International journal of …, 2006 - journals.sagepub.com
When conducting photo elicitation interviews (PEI), researchers introduce photographs into
the interview context. Although PEI has been employed across a wide variety of disciplines …
the interview context. Although PEI has been employed across a wide variety of disciplines …
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
Although advances have been made in understanding the role of hypoxia in the stem cell
niche, almost nothing is known about a potentially similar role of hypoxia in maintaining the …
niche, almost nothing is known about a potentially similar role of hypoxia in maintaining the …
Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
Background Identification of robust biomarkers of malignancy and methods to establish
disease progression is a major goal in paediatric neuro-oncology. We investigated whether …
disease progression is a major goal in paediatric neuro-oncology. We investigated whether …
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study
…, PC Adamson, JM Reid, L Xu, S Baruchel… - Journal of clinical …, 2008 - ascopubs.org
Purpose We conducted a pediatric phase I trial of the vascular endothelial growth factor (VEGF)–neutralizing
antibody bevacizumab (BV). Primary aims included estimating the …
antibody bevacizumab (BV). Primary aims included estimating the …
[PDF][PDF] Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma
…, D Stephens, U Tabori, S Baruchel - Journal of clinical …, 2012 - academia.edu
… Eric Bouffet, Regina Jakacki, Stewart Goldman, Darren Hargrave, Cynthia Hawkins,
Manohar Shroff, Juliette Hukin, Ute Bartels, Nicholas Foreman, Stewart Kellie, Joanne …
Manohar Shroff, Juliette Hukin, Ute Bartels, Nicholas Foreman, Stewart Kellie, Joanne …
The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus
S Baruchel, MA Wainberg - Journal of leukocyte biology, 1992 - academic.oup.com
This review describes the potential role of oxidative stress as a cofactor of disease
progression from asymptomatic human immunodeficiency virus (HIV) infection to the acquired …
progression from asymptomatic human immunodeficiency virus (HIV) infection to the acquired …
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group …
…, A Lee, JM Reid, S Baruchel… - Journal of clinical …, 2013 - ascopubs.org
Purpose Pazopanib, an oral multikinase angiogenesis inhibitor, prolongs progression-free
survival in adults with soft tissue sarcoma (STS). A phase I pharmacokinetic and …
survival in adults with soft tissue sarcoma (STS). A phase I pharmacokinetic and …
[PDF][PDF] Whey proteins as a food supplement in HIV-seropositive individuals
S Baruchel, G Bounous, J Falutz… - Clin Invest …, 1993 - xn--vivetussueoshoy-7qb.com
On the basis of numerous animal experiments, a pilot study was undertaken to evaluate the
effect of undenatured, biologically active, dietary whey protein in 3 HIV-seropositive …
effect of undenatured, biologically active, dietary whey protein in 3 HIV-seropositive …
Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial
…, D Stephens, M Weinstein, N Ho, S Baruchel - …, 2007 - publications.aap.org
OBJECTIVES. Oral systemic corticosteroids are the mainstay of treatment for problematic
hemangiomas; however, current information is based on anecdotal experience and …
hemangiomas; however, current information is based on anecdotal experience and …